227 related articles for article (PubMed ID: 27027350)
1. Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets.
Kim BG; Kang S; Han HH; Lee JH; Kim JE; Lee SH; Cho NH
Oncotarget; 2016 May; 7(19):27468-78. PubMed ID: 27027350
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
3. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
4. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
5. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
6. miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
Lee J; Kim HE; Song YS; Cho EY; Lee A
Breast Cancer Res Treat; 2019 Jul; 176(1):119-130. PubMed ID: 30989460
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
8. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.
Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S
Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720
[TBL] [Abstract][Full Text] [Related]
9. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.
Kang H; Kim C; Lee H; Rho JG; Seo JW; Nam JW; Song WK; Nam SW; Kim W; Lee EK
Cell Death Differ; 2016 Mar; 23(3):484-95. PubMed ID: 26337669
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
[TBL] [Abstract][Full Text] [Related]
14. Mechanical compression induces VEGFA overexpression in breast cancer via DNMT3A-dependent miR-9 downregulation.
Kim BG; Gao MQ; Kang S; Choi YP; Lee JH; Kim JE; Han HH; Mun SG; Cho NH
Cell Death Dis; 2017 Mar; 8(3):e2646. PubMed ID: 28252641
[TBL] [Abstract][Full Text] [Related]
15. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
[TBL] [Abstract][Full Text] [Related]
16. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
[TBL] [Abstract][Full Text] [Related]
17. The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model.
Stankevicins L; Barat A; Dessen P; Vassetzky Y; de Moura Gallo CV
PLoS One; 2017; 12(3):e0173756. PubMed ID: 28346474
[TBL] [Abstract][Full Text] [Related]
18. miR-410-3p suppresses breast cancer progression by targeting Snail.
Zhang YF; Yu Y; Song WZ; Zhang RM; Jin S; Bai JW; Kang HB; Wang X; Cao XC
Oncol Rep; 2016 Jul; 36(1):480-6. PubMed ID: 27221455
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
Xie F; Hosany S; Zhong S; Jiang Y; Zhang F; Lin L; Wang X; Gao S; Hu X
PLoS One; 2017; 12(10):e0185565. PubMed ID: 29016617
[TBL] [Abstract][Full Text] [Related]
20. MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration.
Li P; Sheng C; Huang L; Zhang H; Huang L; Cheng Z; Zhu Q
Breast Cancer Res; 2014 Nov; 16(6):473. PubMed ID: 25394902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]